Bendamustine is safe and effective for lymphodepletion before tisagenlecleucel in patients with refractory or relapsed large B-cell lymphomas
Guido Ghilardi, Elise A. Chong, Jakub Svoboda, Philipp Wohlfarth, Sunita D. Nasta, Staci Williamson, J.D. Landsburg, James N. Gerson, Stefan K. Barta, Raymone Pajarillo, Jessie Myers, A.I. Chen, Levanto Schachter, Rebecca Yelton, Hatcher J. Ballard, Alexandria Hodges Dwinal, Shannon Gier, Danielle Victoriano, Erin L. Weber, Ellen Napier, Alfred L. Garfall, David L. Porter, Ulrich Jäger, Richard T. Maziarz, Marco Ruella, Stephen J. Schuster
Topics & Concepts
FludarabineMedicineCytokine release syndromeBendamustineInternal medicineCyclophosphamideOncologyRituximabChemotherapyLymphomaChimeric antigen receptorImmunotherapyCancerCAR-T cell therapy researchIntegrated Circuits and Semiconductor Failure AnalysisAdvancements in Semiconductor Devices and Circuit Design